2m 2m 2m 2m 2m 2m 2m
Alnylam Pharma (ALNY)
NASDAQ
$288.25+$1.83 (+0.64%)
Price as of Jun 23, 2026 5:54 PM EDT- $38.2BMarket Cap
- -8.53%1-Year Change
- BiotechnologyIndustry
Alnylam Pharma (ALNY)
$288.25+$1.83 (+0.64%)
Earnings Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.18% | ||
12-Month Momentum | -3.62% | ||
3-Month Risk Adjusted Momentum | -32.32% | ||
12-Month Risk Adjusted Momentum | -10.11% |
True Yield
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.49% | ||
Net Debt Paydown Yield | -0.003% |
Financial Health Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 9 |